The role of FDG-PET in Hodgkin lymphoma

The role of FDG-PET in Hodgkin lymphoma

18-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) is currently the most valuable imaging technique in Hodgkin lymphoma. Since its first use in lymphomas in the 1990s, it has become the gold standard in the staging and end-of-treatment remission assessment...

Full description

Bibliographic Details
Main Authors:	Edyta Subocz, Janusz Hałka, Mirosław Dziuk
Format:	Article
Language:	English
Published:	Termedia Publishing House 2017-06-01
Series:	Contemporary Oncology
Subjects:	positron emission tomography Hodgkin lymphoma staging interim PET restaging
Online Access:	https://www.termedia.pl/The-role-of-FDG-PET-in-Hodgkin-lymphoma,3,30170,1,1.html

Similar Items

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
by: Conrad-Amadeus Voltin, et al.
Published: (2020-03-01)

Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence
by: Piva R, et al.
Published: (2017-07-01)

18FDG PET in lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01)

The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children
by: N S Kulichkina, et al.
Published: (2017-09-01)

Inter-reader reliability of early FDG-PET/CT response assessment using the Deauville Scale after 2 cycles of intensive chemotherapy (OEPA) in Hodgkin’s Lymphoma
by: Kluge, Regine, et al.
Published: (2016)

The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas
by: N. G. Chanchikova, et al.
Published: (2021-07-01)

Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
by: Khadega A. Abuelgasim, et al.
Published: (2021-01-01)

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma
by: Liao CC, et al.
Published: (2017-11-01)

The Role of PET/CT to Detect Bone Marrow Involvement in Hodgkin Lymphoma
by: Ali ESER, et al.
Published: (2019-04-01)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
by: Andrea Gallamini, et al.
Published: (2021-08-01)

Current Issues in Histology, Biology and Prognosis of Hodgkin Lymphoma
by: Marjanović Goran, et al.
Published: (2017-06-01)

Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma
by: VG Potapenko, et al.
Published: (2016-10-01)

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnostic Evaluation of Carcinoma Urinary Bladder: Comparison with Computed Tomography
by: Dhritiman Chakraborty, et al.
Published: (2014-01-01)

A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario
by: Thais Bascuas, et al.
Published: (2016-11-01)

Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study
by: Cecilia Marini, et al.
Published: (2021-08-01)

Foreign Body Reaction with High Standard Uptake Value Level in 18-FDG PET/CT Mimicking Relapse in an 8-Year-Old Patient Diagnosed with Hodgkin Lymphoma: A Case Report
by: Derya Erdoğan, et al.
Published: (2013-05-01)

State-of-the-Art research on "Lymphomas: role of molecular imaging for staging, prognostic evaluation and treatment response"
by: Lale eKostakoglu, et al.
Published: (2013-09-01)

PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Multiple osteolytic lesions due to Double-Expressor Primary non‑Hodgkin Lymphoma of the Bone
by: Sotirios Papageorgiou, et al.
Published: (2021-07-01)

Current status of PET/CT in the diagnosis and follow up of lymphomas
by: Carlos Alberto Buchpiguel
Published: (2011-01-01)

Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
by: Pierre Decazes, et al.
Published: (2020-10-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
by: Lars Kurch, et al.
Published: (2021-09-01)

Positron emission tomography with 2-[18F]-Fluoro-2-Deoxy-D-Glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil
by: Juliano Julio Cerci, et al.
Published: (2009-06-01)

Determination of Hodgkin and non-Hodgkin lymphoma stage with combined positron-emission and computed tomography
by: I. V. Boikov, et al.
Published: (2011-12-01)

The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations
by: Yiyan Liu
Published: (2016-09-01)

Heterogeneous marrow uptake on FDG PET/CT is not always a sign of lymphomatous involvement
by: Arun Kumar Reddy Gorla, et al.
Published: (2016-01-01)

Primary mediastinal large B-cell lymphoma: Clinical features, prognostic factors and survival with RCHOP in Arab patients in the PET scan era
by: Salem Al Shemmari, et al.
Published: (2014-01-01)

Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT
by: Thalles H. Ribeiro, et al.

The relationships between bone marrow trephine biopsy findings and Fluorine-18 Fluorodeoxyglucose positron emission tomography-computed tomography (F-18 FDG PET-CT) scan bone marrow uptake in Hodgkin’s lymphoma at initial staging.
by: Mkhize, Ntombifikile Nomasonto
Published: (2015)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
by: Marta Milhões, et al.
Published: (2015-11-01)

MAGNETIC RESONANCE IMAGING DIAGNOSIS OF LUNG LESIONS IN LYMPHOMA
by: Kharuzhyk S. A.
Published: (2020-06-01)

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging and Positron Emission Tomography Combined with Computed Tomography in the Staging of Lymphomas
by: S. A. Kharuzhyk, et al.
Published: (2020-01-01)

Thymic hyperplasia after mRNA based Covid-19 vaccination
by: Julia von Tresckow, Dr., et al.
Published: (2021-12-01)

Predictors of metabolic response in propensity-matched lymphoma patients on interim 18F-fluorodeoxyglucose positron-emission tomography/computed tomography using standardized imaging and reporting protocol: Do we really have one?
by: Nosheen Fatima, et al.
Published: (2019-01-01)

Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma
by: Moheieldin M Abouzied, et al.
Published: (2017-01-01)

Intra- and inter-observer agreement in the visual interpretation of interim 18F-FDG PET/CT in malignant lymphoma: influence of clinical information
by: Arimoto, Maya
Published: (2018)

A tomografia por emissão de pósitron com 18F-fluoro-desoxi-glicose (PET-FDG) na avaliação de resposta precoce à quimioterapia em pacientes portadores de linfoma de Hodgkin
by: Juliano Julio Cerci
Published: (2010)

A tomografia por emissão de pósitron com 18F-fluoro-desoxi-glicose (PET-FDG) na avaliação de resposta precoce à quimioterapia em pacientes portadores de linfoma de Hodgkin
by: Cerci, Juliano Julio
Published: (2010)

18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma
by: Yanping Jiang, et al.
Published: (2020-01-01)

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
by: Amr Elsayed M. Hussien, et al.
Published: (2015-01-01)